Disease | thromboembolism |
Phenotype | C0035078|renal failure |
Sentences | 3 |
PubMedID- 21132647 | The aim of this study was to evaluate the risk of bleeding when lmwh is used as an anticoagulant in hemodialysis or for treatment of acute thromboembolic disease in patients with renal failure. |
PubMedID- 26288730 | Beside potential risks associated with all blood products, non-infectious reactions including systemic symptoms (headache, back pain, nausea, and vomiting), renal failure, single cases of aseptic meningitis, venous thromboembolism, myocardial infarction, and retinal vein occlusion are described [21]. |
PubMedID- 24986775 | Specifically, patients with coronary artery disease with inducible ischemia, congestive heart failure, advanced chronic obstructive pulmonary disease, uncontrolled diabetes, peripheral vascular disease, renal failure, morbid obesity, history of venous thromboembolism, or those who were older than 75 years were not considered eligible for same-day btka. |
Page: 1